# Leadership, Planning and Evaluation

> **NIH NIH P30** · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2021 · $211,909

## Abstract

LEADERSHIP, PLANNING AND EVALUATION – ABSTRACT
Strategic planning and evaluation activities have guided the development of the Stephenson Cancer Center
(SCC) since inception. Upon being appointed SCC Director in 2006, Dr. Robert Mannel worked with University
of Oklahoma (OU) senior leadership to develop a five-year Strategic Plan (2007-2011) in order to establish the
organizational framework, secure the institutional commitments and attract and develop the scientific and
administrative talent on which to build an academic cancer center worthy of NCI designation. Subsequent
Strategic Plans were developed for the 2012-2016 and 2017-2021 periods to advance these efforts. Progress
towards the SCC's strategic goals is overseen by the SCC's senior leadership team (composed of the Director,
Deputy Director for Clinical Affairs and six Associate Directors) and a well-developed oversight and advisory
structure, which includes formal review of progress from both external and internal entities.
External input comes from the SCC's External Advisory Board (EAB), which is comprised of highly respected
scientists and cancer center leaders and provides the SCC Director with critical evaluation and assessment of
SCC programmatic, shared resource and other infrastructure development. In addition, the SCC regularly
invites nationally respected cancer center leaders to visit the SCC and provide focused strategic input on SCC
development. An annual strategic planning process involving SCC leadership and a well-developed internal
committee structure also contributes to effective organizational oversight, planning and evaluation at the SCC.
This committee structure includes a Governance Council (institutional oncology service line stakeholders),
Leadership Committee (SCC Director and senior leadership team), Research Steering Committee (SCC
research leadership), Shared Resource Internal Advisory Boards, Clinical Management Committee (SCC
clinical stakeholders) and Multidisciplinary Disease-Site Committees. In addition, the SCC sponsors or
otherwise supports a host of other activities – including an annual Cancer Research Symposium, Research
Program meetings, and ad hoc planning meetings – that contribute to a broad-based process promoting
stakeholder inclusion, organizational communication and goal-oriented decision making.
Standing quarterly meetings between Dr. Mannel and Dr. Stephen Prescott, President, Oklahoma Medical
Research Foundation (the SCC's proposed consortium partner), ensure that proper planning and evaluation is
given to the alignment and integration of cancer research activities at SCC and OMRF.

## Key facts

- **NIH application ID:** 10177896
- **Project number:** 5P30CA225520-04
- **Recipient organization:** UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
- **Principal Investigator:** ROBERT S. MANNEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $211,909
- **Award type:** 5
- **Project period:** 2018-05-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10177896

## Citation

> US National Institutes of Health, RePORTER application 10177896, Leadership, Planning and Evaluation (5P30CA225520-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10177896. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*